Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties

ACS Nano

Volumn 10, Issue 3, 2016, Pages 3723-3737

  Bigdeli, Arafeh ^a   Palchetti, Sara ^b   Pozzi, Daniela ^b   Hormozi Nezhad, Mohammad Reza ^a   Baldelli Bombelli, Francesca ^c   Caracciolo, Giulio ^b   Mahmoudi, Morteza ^d,e  

^a SHARIF UNIVERSITY OF TECHNOLOGY   (Iran)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c POLITECNICO DI MILANO   (Italy)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer; cell viability; cellular uptake; liposomes; protein corona; QSAR

Indexed keywords

CELL CULTURE; COMPUTATIONAL CHEMISTRY; DATA MINING; DISEASES; MOLECULAR GRAPHICS; PROTEINS;

CANCER; CELL VIABILITY; CELLULAR UPTAKE; PROTEIN CORONAS; QSAR;

LIPOSOMES;

LIPOSOME; PROTEIN CORONA;

CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HELA CELL LINE; HUMAN; METABOLISM; MOLECULAR MODEL; NEOPLASM; PEPTIDE MAPPING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HELA CELLS; HUMANS; LIPOSOMES; MODELS, MOLECULAR; NEOPLASMS; PEPTIDE MAPPING; PROTEIN CORONA; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84961926971     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.6b00261     Document Type: Article

References (36)

1. Allen, T. M.; Cullis, P. R. Liposomal Drug Delivery Systems: From Concept to Clinical Applications Adv. Drug Delivery Rev. 2013, 65, 36-48 10.1016/j.addr.2012.09.037
2. Lasic, D. D.; Papahadjopoulos, D. Medical Applications of Liposomes; Elsevier Science: Amsterdam, 1998; pp 1-13.
3. Al-Jamal, W.; Kostarelos, K. Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine Acc. Chem. Res. 2011, 44, 1094-1104 10.1021/ar200105p
4. Lynch, I.; Salvati, A.; Dawson, K. A. Protein-nanoparticle Interactions: What Does the Cell See? Nat. Nanotechnol. 2009, 4, 546-547 10.1038/nnano.2009.248
5. Walczyk, D.; Bombelli, F. B.; Monopoli, M. P.; Lynch, I.; Dawson, K. A. What the Cell "sees" in Bionanoscience J. Am. Chem. Soc. 2010, 132, 5761-5768 10.1021/ja910675v
6. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K. A. Nanoparticle Size and Surface Properties Determine the Protein Corona with Possible Implications for Biological Impacts Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 14265-14270 10.1073/pnas.0805135105
7. Walkey, C. D.; Chan, W. C. W. Understanding and Controlling the Interaction of Nanomaterials with Proteins in a Physiological Environment Chem. Soc. Rev. 2012, 41, 2780-2799 10.1039/C1CS15233E
8. Caracciolo, G. Liposome-Protein Corona in a Physiological Environment: Challenges and Opportunities for Targeted Delivery of Nanomedicines Nanomedicine 2015, 11, 543-557 10.1016/j.nano.2014.11.003
9. Pozzi, D.; Colapicchioni, V.; Caracciolo, G.; Piovesana, S.; Capriotti, A. L.; Palchetti, S.; Grossi, S. D.; Riccioli, A.; Amenitsch, H.; Lagana, A. Effect of Polyethyleneglycol (PEG) Chain Length on the Bio-nano-interactions Between PEGylated Lipid Nanoparticles and Biological Fluids: From Nanostructure to Uptake in Cancer Cells Nanoscale 2014, 6, 2782-2792 10.1039/c3nr05559k
10. Capriotti, A. L.; Caracciolo, G.; Cavaliere, C.; Foglia, P.; Pozzi, D.; Samperi, R.; Lagana, A. Do Plasma Proteins Distinguish Between Liposomes of Varying Charge Density? J. Proteomics 2012, 75, 1924-1932 10.1016/j.jprot.2012.01.003
11. Barran Berdon, A. L.; Pozzi, D.; Caracciolo, G.; Capriotti, A. L.; Caruso, G.; Cavaliere, C.; Riccioli, A.; Palchetti, S.; Lagana, A. Time Evolution of Nanoparticle-Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery Langmuir 2013, 29, 6485-6494 10.1021/la401192x
12. Lundqvist, M. Nanoparticles: Tracking Protein Corona over Time Nat. Nanotechnol. 2013, 8, 701-702 10.1038/nnano.2013.196
13. Mahmoudi, M.; Abdelmonem, A. M.; Behzadi, S.; Clement, J. H.; Dutz, S.; Ejtehadi, M. R.; Hartmann, R.; Kantner, K.; Linne, U.; Maffre, P.; Metzler, S.; Moghadam, M. K.; Pfeiffer, C.; Rezaei, M.; Ruiz-Lozano, P.; Serpooshan, V.; Shokrgozar, M. A.; Nienhaus, G.; Ulrich; Parak, W. J. Temperature: The "Ignored" Factor at the NanoBio Interface ACS Nano 2013, 7, 6555-6562 10.1021/nn305337c
14. Caracciolo, G.; Pozzi, D.; Capriotti, A. L.; Cavaliere, C.; Foglia, P.; Amenitsch, H.; Lagana, A. Evolution of the Protein Corona of Lipid Gene Vectors as a Function of Plasma Concentration Langmuir 2011, 27, 15048-15053 10.1021/la202912f
15. Hajipour, M. J.; Laurent, S.; Aghaie, A.; Rezaee, F.; Mahmoudi, M. Personalized Protein Coronas: A "key" Factor at the Nanobiointerface Biomater. Sci. 2014, 2, 1210-1221 10.1039/C4BM00131A
16. Caracciolo, G.; Pozzi, D.; Capriotti, A. L.; Cavaliere, C.; Piovesana, S.; La Barbera, G.; Amici, A.; Lagana, A. The Liposome-Protein Corona in Mice and Humans and Its Implications for in vivo Delivery J. Mater. Chem. B 2014, 2, 7419-7428 10.1039/C4TB01316F
17. Walkey, C. D.; Olsen, J. B.; Song, F.; Liu, R.; Guo, H.; Olsen, D. W. H.; Cohen, Y.; Emili, A.; Chan, W. C. W. Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles ACS Nano 2014, 8, 2439-2455 10.1021/nn406018q
18. Liu, K.; Jiang, W.; Walkey, C. D.; Chan, W. C. W.; Cohen, Y. Prediction of Nanoparticles-Cell association based on Corona Proteins and Physicochemical Properties Nanoscale 2015, 7, 9664-9675 10.1039/C5NR01537E
19. Pozzi, D.; Caracciolo, G.; Digiacomo, L.; Colapicchioni, V.; Palchetti, S.; Capriotti, A. L.; Cavaliere, C.; Zenezini Chiozzi, R.; Puglisi, A.; Lagana, A. The biomolecular corona of nanoparticles in circulating biological media Nanoscale 2015, 7, 13958-13966 10.1039/C5NR03701H
20. Tenzer, S.; Docter, D.; Kuharev, J.; Musyanovych, A.; Fetz, V.; Hecht, R.; Schlenk, F.; Fischer, D.; Kiouptsi, L.; Reinhardt, C.; Landfester, K.; Schild, H.; Maskos, M.; Knauer, S. K.; Stauber, R. H. Rapid Formation of Plasma Protein Corona Critically Affects Nanoparticle Pathophysiology Nat. Nanotechnol. 2013, 8, 772-781 10.1038/nnano.2013.181
21. Doorley, G. W.; Payne, C. K. Cellular Binding of Nanoparticles in the Presence of Serum Proteins Chem. Commun. 2011, 47, 466-468 10.1039/C0CC02618B
22. Huhn, D.; Kantner, K.; Geidel, C.; Brandholt, S.; Cock, I. D.; Soenen, S. J. H.; Rivera-Gil, P.; Montenegro, J. M.; Braeckmans, K.; Mullen, K.; Nienhaus, G. U.; Klapper, M.; Parak, W. J. Polymer-Coated Nanoparticles Interacting with Proteins and Cells: Focusing on the Sign of the Net Charge ACS Nano 2013, 7, 3253-3263 10.1021/nn3059295
23. Lynch, I.; Dawson, K. A. Protein-Nanoparticle Interactions Nano Today 2008, 3, 40-47 10.1016/S1748-0132(08)70014-8
24. Tenzer, S.; Docter, D.; Rosfa, S.; Wlodarski, A.; Kuharev, J.; Rekik, A.; Knauer, S. K.; Bantz, C.; Nawroth, T.; Bier, C.; Sirirattanapan, J.; Wolf, M.; Lennart, T.; Reinhard, Z.; Michael, M.; Hansjorg, S.; Stauber, R. H. Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis ACS Nano 2011, 5, 7155-7167 10.1021/nn201950e
25. Filippakopoulos, P.; Qi, J.; Picaud, S.; Shen, Y.; Smith, W. B.; Fedorov, O.; Morse, E. M.; Keates, T.; Hickman, T. T.; Felletar, I.; Phipott, M.; Munro, S.; McKeown, M. R.; Wang, Y.; Christie, A. L.; West, N.; Cameron, M. J.; Schwartz, B.; Heightman, T. D.; Thangue, N. L.; French, C. A.; Wiest, O.; Kung, A. L.; Knapp, S.; Bradner, J. E. Selective Inhibition of BET Bromodomains Nature 2010, 468, 1067-1073 10.1038/nature09504
26. Ma, D. L.; Liu, L. J.; Leung, K. H.; Chen, Y. T.; Zhong, H. J.; Chan, D. S. H.; Wang, H. M. D.; Leung, C. H. Antagonizing STAT3 Dimerization with a Rhodium(III) Complex Angew. Chem., Int. Ed. 2014, 53, 9178-9182 10.1002/anie.201404686
27. Provencher, S. W. A Constrained Regularization Method for Inverting Data Represented by Linear Algebraic or Integral Equations Comput. Phys. Commun. 1982, 27, 213-227 10.1016/0010-4655(82)90173-4
28. Gemperline, P. In Practical Guide to Chemometrics, 2 nd ed.; CRC Press, Taylor and Francis, LLC, 2006; pp 111-116.
29. Miller, J. N.; Miller, J. C. In Statistics and Chemometrics for Analytical Chemistry, 5 th ed.; Pearson: Harlow, U.K., 2005; pp 228-237.
30. MacKay, D. J. C. A Practical Bayesian Framework for Backpropagation Networks Neural Comput. 1992, 4, 448-472 10.1162/neco.1992.4.3.448
31. Anderson, C. M.; Bro, R. Variable Selection in Regression J. Chemom. 2010, 24, 728-737 10.1002/cem.1360
32. Gramatica, P. Principles of QSAR Models Validation: Internal and External QSAR Comb. Sci. 2007, 26, 694-701 10.1002/qsar.200610151
33. Eriksson, L.; Jaworska, J.; Worth, A. P.; Cronin, M. T. D.; McDowell, R. M.; Gramatica, P. Methods for Reliability, Uncertainty Assessment, and Applicability Evaluations of Classification and Regression Based QSARs Environ. Health Perspect. 2003, 111, 1361-1375 10.1289/ehp.5758
34. Puzyn, T.; Leszczynska, D.; Leszczynski, J. Toward the Development of 'Nano-QSARs': Advances and Challenges Small 2009, 5, 2494-2509 10.1002/smll.200900179
35. Guha, R.; Jurs, P. C. Interpreting Computational Neural Network QSAR models: A Measure of Descriptor Importance J. Chem. Inf. Model. 2005, 45, 800-806 10.1021/ci050022a
36. Tropsha, A.; Gramatica, P.; Gombar, P. V. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models QSAR Comb. Sci. 2003, 22, 69-77 10.1002/qsar.200390007